Arbutus Biopharma Corporation
ABUS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36,330 | $26,285 | $30,776 | $109,282 |
| Short-Term Investments | $86,293 | $99,718 | $116,137 | $46,035 |
| Receivables | $2,409 | $1,776 | $1,352 | $899 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,284 | $4,248 | $2,874 | $4,445 |
| Total Curr. Assets | $127,316 | $132,027 | $151,139 | $160,661 |
| Property Plant & Equip (Net) | $4,357 | $6,090 | $6,814 | $8,075 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $6,284 | $37,363 | $35,688 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $34 | $0 | $103 | $61 |
| Total NC Assets | $4,391 | $12,374 | $44,280 | $43,824 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $131,707 | $144,401 | $195,419 | $204,485 |
| Liabilities | – | – | – | – |
| Payables | $2,316 | $3,223 | $3,520 | $3,174 |
| Short-Term Debt | $483 | $425 | $372 | $383 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7,571 | $11,791 | $16,456 | $0 |
| Other Curr. Liab. | $5,248 | $7,048 | $12,509 | $7,664 |
| Total Curr. Liab. | $15,618 | $22,487 | $32,857 | $11,221 |
| LT Debt | $806 | $8,296 | $12,180 | $18,527 |
| Deferred Rev, NC | $2,863 | $0 | $5,999 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $15,054 | $7,600 | $7,531 | $5,298 |
| Total NC Liab. | $18,723 | $15,896 | $25,710 | $23,825 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,289 | $1,768 | $1,815 | $2,614 |
| Total Liabilities | $34,341 | $38,383 | $58,567 | $35,046 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,410,025 | $1,349,821 | $1,318,737 | $1,286,636 |
| Retained Earnings | -$1,346,572 | -$1,276,652 | -$1,203,803 | -$1,134,347 |
| AOCI | -$48,135 | -$48,421 | -$50,488 | -$48,335 |
| Other Equity | $82,048 | $81,270 | $72,406 | $65,485 |
| Total Equity | $97,366 | $106,018 | $136,852 | $169,439 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $131,707 | $144,401 | $195,419 | $204,485 |
| Net Debt | -$35,041 | -$17,564 | -$18,224 | -$90,372 |